
Livestock Healthcare Market Report 2026
Global Outlook – By Product Type (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Other Types), By Livestock Animal (Poultry, Swine, Cattle, Sheep And Goats, Horse, Other Animals), By End User (Reference Laboratories, Point-of-care Testing or In-house Testing, Veterinary Hospitals and Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Livestock Healthcare Market Overview
• Livestock Healthcare market size has reached to $58.41 billion in 2025 • Expected to grow to $96.73 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Surge In Livestock Population Fuels Growth In The Livestock Healthcare Market • Market Trend: Pioneering Livestock Healthcare With Advanced Ayurvedic Formulations • North America was the largest region in 2025.What Is Covered Under Livestock Healthcare Market?
Livestock healthcare refers to the development of health-building and illness prevention, detection, and management strategies that support the health and welfare of farm animals. They are used for improving the health, welfare, and productivity of livestock. The main types of livestock healthcare are vaccines, pharmaceuticals, feed additives, diagnostics, and other types. Feed additives are single ingredients or substances used in animal nutrition to improve the quality of feed and animal-derived foods. It contributes to the health and performance of the animals. These are applied to various livestock animals such as poultry, swine, cattle, sheep and goats, horses, and others and are used by various end users such as reference laboratories, point-of-care testing or in-house testing, veterinary hospitals and clinics, and others.
What Is The Livestock Healthcare Market Size and Share 2026?
The livestock healthcare market size has grown rapidly in recent years. It will grow from $58.41 billion in 2025 to $64.36 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing livestock population, growing awareness of livestock health and productivity, advancements in veterinary pharmaceuticals and vaccines, expansion of veterinary hospitals and clinics, rising demand for animal-derived food products.What Is The Livestock Healthcare Market Growth Forecast?
The livestock healthcare market size is expected to see rapid growth in the next few years. It will grow to $96.73 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to adoption of precision medicine and genomics in livestock care, integration of digital diagnostics and cloud-based monitoring, increasing demand for specialty and combination drugs, growth in point-of-care testing and in-house diagnostics, rising focus on sustainable and welfare-driven livestock management. Major trends in the forecast period include growing adoption of vaccines for livestock disease prevention, rising demand for prescription and over-the-counter pharmaceuticals, increasing use of nutritional feed additives and probiotics, expansion of molecular and immunoassay diagnostics, development of medical devices, laboratory equipment, and alternative treatments.Global Livestock Healthcare Market Segmentation
1) By Product Type: Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Other Types 2) By Livestock Animal: Poultry, Swine, Cattle, Sheep And Goats, Horse, Other Animals 3) By End User: Reference Laboratories, Point-of-care Testing or In-house Testing, Veterinary Hospitals and Clinics, Other End-Users Subsegments: 1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines, DNA Vaccines, Recombinant Vaccines 2) By Pharmaceuticals: Prescription Medications, Over-the-Counter Medications, Biopharmaceuticals, Generic Drugs, Specialty Pharmaceuticals, Combination Drugs 3) By Feed Additives: Nutritional Additives (Vitamins, Minerals), Antibiotics, Probiotics, Enzymes, Amino Acids, Flavoring Agents, Antioxidants 4) By Diagnostics: Molecular Diagnostics, Immunoassays, Point-of-Care Testing, Imaging Diagnostics, Histopathology, Genetic Testing 5) By Other Types: Medical Devices, Laboratory Equipment, Research Reagents, Therapeutic Devices, Alternative TreatmentsWhat Is The Driver Of The Livestock Healthcare Market?
The increasing livestock population is expected to propel the growth of the livestock healthcare market going forward. Livestock population refers to the total number of domesticated animals raised by humans for various purposes, such as food, fiber, labor, and other products. Livestock population is rising due to increasing demand for animal-based food products, as farmers expand herds to meet growing consumption and economic opportunities. The livestock population requires livestock healthcare to maintain economic stability, ensure food security, support farmers' livelihoods, promote sustainable agricultural practices, and prevent and control the spread of diseases. For instance, in March 2024, according to the Department for Environment, Food, and Rural Affairs, a UK-based ministerial department, the number of hens and pullets laying eggs for eating rose from 40.44 million in 2022 to 41.07 million in 2023, while the breeding flock increased from 52.46 million to 53.79 million during the same period. Therefore, the increasing livestock population is driving the growth of the livestock healthcare industry.Key Players In The Global Livestock Healthcare Market
Major companies operating in the livestock healthcare market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Alltech Inc., Virbac SA, Ceva Santé Animale, Phibro Animal Health Corporation, Avivagen Inc., Dechra Pharmaceuticals plc, Huvepharma AD, Vetoquinol SA, Laboratorios Hipra S.A., Anpario plc, Kemin Industries Inc., Norbrook Laboratories Ltd., Alivira Animal Health Limited, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Hester Biosciences Limited, Vets Plus Inc., Phytobiotics Futterzusatzstoffe GmbH, Delacon Biotechnik GmbH, Bimeda Holdings plc, InovetGlobal Livestock Healthcare Market Trends and Insights
Major companies operating in the livestock healthcare market are focused on introducing advanced solutions, such as ayurvedic formulations, to gain a competitive edge in the market. Ayurvedic formulations are traditional herbal preparations and remedies used in Ayurveda, a system of medicine with historical roots based on plants, animals extract, and minerals. For instance, in September 2023, Milma, an India-based dairy company launched ethno-veterinary medicines. Ethno-veterinary medicines are medicines made from Ayurvedic formulations and are designed to treat animal diseases. Ethno-veterinary medicines are used as low-cost alternatives to allopathic veterinary drugs. These medicines lessen the burden of veterinary expenses on farmers and provide a cost-effective solution for animal healthcare. These medicines are a simple, cost-effective, farmer-friendly tool that are used as preventives and curatives.What Are Latest Mergers And Acquisitions In The Livestock Healthcare Market?
In December 2023, Zenex Animal Health India Private Limited, an India‑based provider of veterinary pharmaceuticals, nutritional supplements, herbal remedies, and animal health solutions, acquired Ayurvet Ltd. for an undisclosed amount. With this acquisition, Zenex aims to strengthen and diversify its animal health portfolio by adding Ayurvet’s established herbal and ayurvedic product range while expanding its geographic footprint and R&D capabilities, particularly in EU markets. Ayurvet Ltd. is an India‑based provider of natural ayurvedic and herbal medicines, feed supplements, and topical treatments for livestock, poultry, and companion animals, with an established presence in multiple international markets including Poland.Regional Outlook
North America was the largest region in the livestock healthcare market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Livestock Healthcare Market?
The livestock healthcare market consists of sales of livestock medications such as biologics and tick medications as well as tools for livestock disease diagnosis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Livestock Healthcare Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $64.36 billion |
| Revenue Forecast In 2035 | $96.73 billion |
| Growth Rate | CAGR of 10.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Livestock Animal, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Alltech Inc., Virbac SA, Ceva Santé Animale, Phibro Animal Health Corporation, Avivagen Inc., Dechra Pharmaceuticals plc, Huvepharma AD, Vetoquinol SA, Laboratorios Hipra S.A., Anpario plc, Kemin Industries Inc., Norbrook Laboratories Ltd., Alivira Animal Health Limited, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Hester Biosciences Limited, Vets Plus Inc., Phytobiotics Futterzusatzstoffe GmbH, Delacon Biotechnik GmbH, Bimeda Holdings plc, Inovet |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
